Roche wants to expand in the market Against Cancer

Switzerland pharmaceutical products company said in a statement that it will acquire a majority share in the business of molecular and Genomics Analysis Foundation Medicine, aiming to expand in cancer immunotherapy. Roche will make an offer for approximately 15.6 million shares of the Foundation to $ 50 each, or about $ 780 million, in addition to invest $ 250 million in purchasing 5 million shares of newly issued Foundation. If completed, Roche will stop from 52.4 to 56.3% of the company and will gain representation on the Board